Viewpoint: Roundup on trial—speculative glyphosate-cancer lawsuits based on ‘junk science’

| | April 19, 2019
roundup spray
Credit: Grant Gerlock/Harvest Public Media
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

“The art of junk science is to brush away just enough detail to reach desired conclusions, while preserving enough to maintain an aura of authoritative science.” This statement by Peter William Huber in his 1991 book Galileo’s Revenge: Junk Science in the Courtroom was never more evident than in current civil trials involving complex scientific and medical studies and associated testifying experts.

Current state and federal trials concerning the use [of] Roundup herbicide “causing” one of the nearly 60 diverse sub-types of Non-Hodgkin’s Lymphoma (NHL) provide a judicial environment amenable for junk science….The first Roundup trial in a San Francisco state court combined causation and “document interpretation” and generated an environment laden with junk science and higher order speculation.

Related article:  EU health commissioner: Anti-vaccine, glyphosate 'conspiracy theories' threaten Europe with 'new middle ages'

The unique trial environment combined with the speculative leaps by plaintiff’s medical expert supported an opinion plaintiff’s rare and idiopathic NHL cancer sub-type was incurred during the first days of Roundup spraying, required a much shorter latency period than significant exposure to well recognized cancer agents and was based upon statistically significant, but not causally associated odds ratios from exploratory case studies of epidemiology.

Read full, original article: Junk Science & U.S. Civil Juries: Roundup Trials

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend